Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2Advanced Malignancies 1

Interventions

Midazolam 2Injections 2zanidatamab 1tislelizumab 1sitravatinib 1repaglinide 1pembrolizumab 1pamiparib 1lenvatinib 1drospirenone 1cemiplimab 1Temozolomide 1Pemetrexed 1Paclitaxel 1Ipilimumab 1HMPL-013 1Gemcitabine 1Ethinyl Estradiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Malignancies × Ethinyl Estradiol × 1 year × Clear all
NCT07340190 2026-04-02

A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies

Novartis

Phase 1 Not yet recruiting
24 enrolled

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡